miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity.
作者信息
Soltani Saber, Zandi Milad
机构信息
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Mol Biol Rep. 2021 Jul;48(7):5809-5810. doi: 10.1007/s11033-021-06378-x. Epub 2021 May 3.
Abstract
摘要
相似文献
1
miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as interesting aspects for COVID-19 treatment and immunity.
Mol Biol Rep. 2021 Jul;48(7):5809-5810. doi: 10.1007/s11033-021-06378-x. Epub 2021 May 3.
2
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects.
Infect Genet Evol. 2022 Mar;98:105207. doi: 10.1016/j.meegid.2022.105207. Epub 2022 Jan 5.
3
[Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome].
Zhonghua Yi Xue Za Zhi. 2018 Nov 6;98(41):3354-3359. doi: 10.3760/cma.j.issn.0376-2491.2018.41.013.
4
Upregulated miR-200c is associated with downregulation of the functional receptor for severe acute respiratory syndrome coronavirus 2 ACE2 in individuals with obesity.
Int J Obes (Lond). 2022 Jan;46(1):238-241. doi: 10.1038/s41366-021-00984-2. Epub 2021 Oct 8.
5
Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection.
Int J Mol Sci. 2022 Jun 14;23(12):6644. doi: 10.3390/ijms23126644.
6
Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
J Infect. 2022 Oct;85(4):418-427. doi: 10.1016/j.jinf.2022.06.030. Epub 2022 Jul 3.
7
ACE2 downregulation in olfactory mucosa: Eosinophilic rhinosinusitis as COVID-19 protective factor?
Allergy. 2021 Sep;76(9):2904-2907. doi: 10.1111/all.14904. Epub 2021 May 28.
8
Up-regulated miR-374a-3p relieves lipopolysaccharides induced injury in CHON-001 cells via regulating Wingless-type MMTV integration site family member 5B.
Mol Cell Probes. 2020 Jun;51:101541. doi: 10.1016/j.mcp.2020.101541. Epub 2020 Feb 21.
9
Downregulation of microRNA-200c-3p reduces damage of hippocampal neurons in epileptic rats by upregulating expression of RECK and inactivating the AKT signaling pathway.
Chem Biol Interact. 2019 Jul 1;307:223-233. doi: 10.1016/j.cbi.2019.04.027. Epub 2019 Apr 21.
10
miRNA-200c-3p is crucial in acute respiratory distress syndrome.
Cell Discov. 2017 Jun 27;3:17021. doi: 10.1038/celldisc.2017.21. eCollection 2017.
引用本文的文献
1
Modulation of RAAS receptors and miRNAs in COVID-19: implications for disease severity, immune response, and potential therapeutic targets.
BMC Infect Dis. 2025 Mar 24;25(1):399. doi: 10.1186/s12879-025-10803-y.
2
MicroRNA‑200c‑3p regulates seawater‑induced acute lung injury via ANGII and ACE2/ANG1‑7 pathways.
Exp Ther Med. 2023 Oct 30;26(6):582. doi: 10.3892/etm.2023.12281. eCollection 2023 Dec.
3
Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients.
J Clin Med. 2022 Dec 29;12(1):283. doi: 10.3390/jcm12010283.
4
Identifying MicroRNA Markers That Predict COVID-19 Severity Using Machine Learning Methods.
Life (Basel). 2022 Nov 23;12(12):1964. doi: 10.3390/life12121964.
5
Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.
Virus Res. 2022 Oct 2;319:198880. doi: 10.1016/j.virusres.2022.198880. Epub 2022 Jul 26.
6
The role of microRNAs in COVID-19 with a focus on miR-200c.
J Circ Biomark. 2022 Mar 21;11:14-23. doi: 10.33393/jcb.2022.2356. eCollection 2022 Jan-Dec.
7
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
Virus Res. 2022 Jan 15;308:198631. doi: 10.1016/j.virusres.2021.198631. Epub 2021 Nov 14.
本文引用的文献
1
microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines.
ExRNA. 2019;1(1):1. doi: 10.1186/s41544-018-0004-7. Epub 2019 Feb 14.
2
The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Biomed Res Int. 2021 Feb 23;2021:6670798. doi: 10.1155/2021/6670798. eCollection 2021.
3
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
Drugs. 2021 Apr;81(5):517-531. doi: 10.1007/s40265-021-01474-5. Epub 2021 Feb 27.
4
Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19.
Front Cell Infect Microbiol. 2021 Jan 28;10:619075. doi: 10.3389/fcimb.2020.619075. eCollection 2020.
5
Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs.
Med Hypotheses. 2021 Jan;146:110415. doi: 10.1016/j.mehy.2020.110415. Epub 2020 Nov 25.
6
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
Cells. 2020 Oct 29;9(11):2374. doi: 10.3390/cells9112374.
7
Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis.
EBioMedicine. 2020 Oct;60:103004. doi: 10.1016/j.ebiom.2020.103004. Epub 2020 Sep 24.
8
Differential microRNA expression in the peripheral blood from human patients with COVID-19.
J Clin Lab Anal. 2020 Oct;34(10):e23590. doi: 10.1002/jcla.23590. Epub 2020 Sep 22.
9
Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications.
Hum Microb J. 2020 Aug;17:100073. doi: 10.1016/j.humic.2020.100073. Epub 2020 Aug 5.
10
The cytokine storm of COVID-19: a spotlight on prevention and protection.
Expert Opin Ther Targets. 2020 Aug;24(8):723-730. doi: 10.1080/14728222.2020.1783243. Epub 2020 Jun 27.
Zotero 插件